PAPER Marchetti M, Priftis K

Effectiveness of the P3-speller in brain-computer interfaces for amyotrophic lateral sclerosis patients: a systematic review and meta-analysis.

Front Neuroeng. 2014;7:12. Epub 2014 May 1 PubMed: 24847247

PAPER Vehviläinen P, Koistinaho J, Gundars G

Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis.

Front Cell Neurosci. 2014;8:126. Epub 2014 May 9 PubMed: 24847211

PAPER Elf K, Shevchenko G, Nygren I, Larsson L, Bergquist J, Askmark H, Artemenko K

Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis.

J Proteomics. 2014 Aug 28;108:55-64. Epub 2014 May 17 PubMed: 24846852

PAPER Mulcahy PJ, Iremonger K, Karyka E, Herranz-Martín S, Shum KT, Tam JK, Azzouz M

Gene therapy: a promising approach to treating spinal muscular atrophy.

Hum Gene Ther. 2014 Jul;25(7):575-86. Epub 2014 Jun 27 PubMed: 24845847

PAPER Lee HJ, Kim KS, Ahn J, Bae HM, Lim I, Kim SU

Human motor neurons generated from neural stem cells delay clinical onset and prolong life in ALS mouse model.

PLoS One. 2014;9(5):e97518. Epub 2014 May 20 PubMed: 24844281

PAPER Dias KS, Viegas C Jr

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease.

Curr Neuropharmacol. 2014 May;12(3):239-55. PubMed: 24851088

PAPER Aggleton JP

Looking beyond the hippocampus: old and new neurological targets for understanding memory disorders.

Proc Biol Sci. 2014 Jul 7;281(1786) PubMed: 24850926

PAPER Benhamú B, Martín-Fontecha M, Vázquez-Villa H, Pardo L, López-Rodríguez ML

Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.

J Med Chem. 2014 Sep 11;57(17):7160-81. Epub 2014 Jun 3 PubMed: 24850589

PAPER Law LL, Barnett F, Yau MK, Gray MA

Effects of functional tasks exercise on older adults with cognitive impairment at risk of Alzheimer's disease: a randomised controlled trial.

Age Ageing. 2014 Nov;43(6):813-20. Epub 2014 May 21 PubMed: 24850540

PAPER Schneider SA, Obeso JA

Clinical and Pathological Features of Parkinson's Disease.

Curr Top Behav Neurosci. 2014 May 22; PubMed: 24850081

PAPER Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Lancet Neurol. 2014 Jun;13(6):614-29. PubMed: 24849862

PAPER Holmes D

Bruno Dubois: transforming the diagnosis of Alzheimer's disease.

Lancet Neurol. 2014 Jun;13(6):541. PubMed: 24849858

PAPER Brayne C

A population perspective on the IWG-2 research diagnostic criteria for Alzheimer's disease.

Lancet Neurol. 2014 Jun;13(6):532-4. PubMed: 24849852

PAPER Wang X, Cattaneo F, Ryno L, Hulleman J, Reixach N, Buxbaum JN

The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.

J Neurosci. 2014 May 21;34(21):7253-65. PubMed: 24849358

PAPER Ma QL, Zuo X, Yang F, Ubeda OJ, Gant DJ, Alaverdyan M, Kiosea NC, Nazari S, Chen PP, Nothias F, Chan P, Teng E, Frautschy SA, Cole GM

Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.

J Neurosci. 2014 May 21;34(21):7124-36. PubMed: 24849348